FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2789087194> ?p ?o ?g. }

• W2789087194 endingPage "477" @default.
• W2789087194 startingPage "467" @default.
• W2789087194 abstract "Treatment-resistant depression (TRD) is common and potentially life-threatening in adults, and the benefits and risks of adjunctive aripiprazole in these patients remain controversial. Therefore, we conducted a meta-analysis of randomized controlled trials (RCTs) to assess the efficacy, acceptability, safety, and quality of life of adjunctive aripiprazole in patients with TRD.RCTs published in PubMed, Web of Science, and Embase were systematically reviewed to evaluate the efficacy and safety profiles of TRD patients who were treated with adjunctive aripiprazole. The main outcome measures included response rate, remission rate, changes from baseline in Montgomery-Asberg Depression Rating Scale (MADRS), Clinical Global Impression-severity (CGI-S), Clinical Global Impression-improvement (CGI-I), 17-Item Hamilton Rating Scale for Depression (HAM-D17), Sheehan Disability scale (SDS), and Inventory of Depressive Symptomatology Self-Report Scale (IDS-SR), discontinuation due to adverse events, and adverse events. Risk ratio (RR) or weight mean difference with 95% confidence intervals (CIs) were pooled using a fixed-effects or random-effects model according to the heterogeneity among studies.A total of 8 RCTs involving 2,260 patients were included in this meta-analysis. Adjunctive aripiprazole was associated with a significantly higher remission rate (RR =1.64, 95% CI: 1.42 to 1.89; P<0.001) and response rate (RR =1.45, 95% CI: 1.13 to 1.87; P=0.004) than other treatments. Moreover, adjunctive aripiprazole had greater changes in MADRS score, CGI-S score, CGI-I score, HAM-D17 score, SDS score, and IDS-SR score. There were more patients treated with adjunctive aripiprazole who discontinued their treatments due to adverse events. The incidence of adverse events was significantly higher in the adjunctive aripiprazole group than in other treatment groups.The adjunctive aripiprazole showed benefits in improving the response rate, remission rate, and the quality of life in patients with TRD. However, clinicians should interpret these findings with caution due to the evidence of potential treatment-related side effects." @default.
• W2789087194 created "2018-03-06" @default.
• W2789087194 creator A5034055316 @default.
• W2789087194 creator A5043557814 @default.
• W2789087194 creator A5071798264 @default.
• W2789087194 creator A5090139570 @default.
• W2789087194 date "2018-02-01" @default.
• W2789087194 modified "2023-10-16" @default.
• W2789087194 title "Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials" @default.
• W2789087194 cites W1780931260 @default.
• W2789087194 cites W183123008 @default.
• W2789087194 cites W1854929367 @default.
• W2789087194 cites W1964435302 @default.
• W2789087194 cites W1971179661 @default.
• W2789087194 cites W1971595028 @default.
• W2789087194 cites W1980153964 @default.
• W2789087194 cites W1981033410 @default.
• W2789087194 cites W1984615306 @default.
• W2789087194 cites W2007880575 @default.
• W2789087194 cites W2020362980 @default.
• W2789087194 cites W2020739757 @default.
• W2789087194 cites W2021939430 @default.
• W2789087194 cites W2033726468 @default.
• W2789087194 cites W2034822289 @default.
• W2789087194 cites W2069407782 @default.
• W2789087194 cites W2070357412 @default.
• W2789087194 cites W2070828096 @default.
• W2789087194 cites W2070895158 @default.
• W2789087194 cites W2080591067 @default.
• W2789087194 cites W2093300144 @default.
• W2789087194 cites W2098923148 @default.
• W2789087194 cites W2107328434 @default.
• W2789087194 cites W2125435699 @default.
• W2789087194 cites W2149402043 @default.
• W2789087194 cites W2150000105 @default.
• W2789087194 cites W2155290877 @default.
• W2789087194 cites W2156098321 @default.
• W2789087194 cites W2156791601 @default.
• W2789087194 cites W2157823046 @default.
• W2789087194 cites W2158562888 @default.
• W2789087194 cites W2163694143 @default.
• W2789087194 cites W2165010366 @default.
• W2789087194 cites W2240430293 @default.
• W2789087194 cites W2293732379 @default.
• W2789087194 cites W2313491356 @default.
• W2789087194 cites W2399110179 @default.
• W2789087194 cites W2588681363 @default.
• W2789087194 cites W2991792334 @default.
• W2789087194 cites W38793130 @default.
• W2789087194 doi "https://doi.org/10.2147/ndt.s156619" @default.
• W2789087194 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5810518" @default.
• W2789087194 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29445284" @default.
• W2789087194 hasPublicationYear "2018" @default.
• W2789087194 type Work @default.
• W2789087194 sameAs 2789087194 @default.
• W2789087194 citedByCount "8" @default.
• W2789087194 countsByYear W27890871942018 @default.
• W2789087194 countsByYear W27890871942019 @default.
• W2789087194 countsByYear W27890871942020 @default.
• W2789087194 countsByYear W27890871942021 @default.
• W2789087194 countsByYear W27890871942022 @default.
• W2789087194 countsByYear W27890871942023 @default.
• W2789087194 crossrefType "journal-article" @default.
• W2789087194 hasAuthorship W2789087194A5034055316 @default.
• W2789087194 hasAuthorship W2789087194A5043557814 @default.
• W2789087194 hasAuthorship W2789087194A5071798264 @default.
• W2789087194 hasAuthorship W2789087194A5090139570 @default.
• W2789087194 hasBestOaLocation W27890871941 @default.
• W2789087194 hasConcept C118552586 @default.
• W2789087194 hasConcept C126322002 @default.
• W2789087194 hasConcept C139719470 @default.
• W2789087194 hasConcept C142724271 @default.
• W2789087194 hasConcept C162324750 @default.
• W2789087194 hasConcept C168563851 @default.
• W2789087194 hasConcept C197934379 @default.
• W2789087194 hasConcept C204787440 @default.
• W2789087194 hasConcept C27081682 @default.
• W2789087194 hasConcept C2776000289 @default.
• W2789087194 hasConcept C2776412080 @default.
• W2789087194 hasConcept C2776867660 @default.
• W2789087194 hasConcept C2778715236 @default.
• W2789087194 hasConcept C2779144063 @default.
• W2789087194 hasConcept C2780051608 @default.
• W2789087194 hasConcept C2780211496 @default.
• W2789087194 hasConcept C3018162438 @default.
• W2789087194 hasConcept C71924100 @default.
• W2789087194 hasConcept C95190672 @default.
• W2789087194 hasConceptScore W2789087194C118552586 @default.
• W2789087194 hasConceptScore W2789087194C126322002 @default.
• W2789087194 hasConceptScore W2789087194C139719470 @default.
• W2789087194 hasConceptScore W2789087194C142724271 @default.
• W2789087194 hasConceptScore W2789087194C162324750 @default.
• W2789087194 hasConceptScore W2789087194C168563851 @default.
• W2789087194 hasConceptScore W2789087194C197934379 @default.
• W2789087194 hasConceptScore W2789087194C204787440 @default.
• W2789087194 hasConceptScore W2789087194C27081682 @default.
• W2789087194 hasConceptScore W2789087194C2776000289 @default.
• W2789087194 hasConceptScore W2789087194C2776412080 @default.

• next